Apr 27 2023: This sample was originally reported as containing Fluorexetamine (3-Fluoro-2-oxo PCE). A certified reference standard became available for 2-Fluoro-2-oxo PCE in early 2023.
All samples analyzed by the DrugsData lab prior to early 2023 that were reported as containing Fluorexetamine have been reexamined in comparison to this new standard. They have all been retroactively revised; they all contain 2-Fluoro-2-oxo PCE, including this sample. To date, no samples tested by DrugsData have contained 3-Fluoro-2-oxo PCE.
Please don't send samples this large to DrugsData.
It's important that samples submitted to this testing program be no more than 200 mg of material (ideally 20 to 50 mg). Keep in mind that just enough to *half* fill a capsule is more than enough. There is no advantage to sending more material, and samples that are too heavy may be delayed or require additional payment.
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our DEA-licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
All samples analyzed by the DrugsData lab prior to early 2023 that were reported as containing Fluorexetamine have been reexamined in comparison to this new standard. They have all been retroactively revised; they all contain 2-Fluoro-2-oxo PCE, including this sample. To date, no samples tested by DrugsData have contained 3-Fluoro-2-oxo PCE.
It's important that samples submitted to this testing program be no more than 200 mg of material (ideally 20 to 50 mg). Keep in mind that just enough to *half* fill a capsule is more than enough. There is no advantage to sending more material, and samples that are too heavy may be delayed or require additional payment.
See how to send in a sample for testing.